PREVIOUS ISSUES

VOLUME 1, ISSUE 4
Harm Reduction: Background, Outcomes, Appraisals and Implications for Future Drug Policy
go to this issue

Harm Reduction – the Idea and the Ideology
Professor Dr A. Hamid Ghodse, Member and Past President, INCB.
When Harm minimization is not harm minimization – Australia as a Case Study
Stuart Reece MBBS (Hons), FRCS (Ed.), FRCS (Glas.), MD, FRACGP
The “Local” Matters: A Brief History of the Tension Between Federal Drug Laws and State and Local Policy
Kevin A. Sabet, Ph.D.
Putting ethics in its place – right at the heart of drug policy debates
Dr Gregory K Pike, PhD
History of Harm Reduction - Provenance and Politics, Part 3
Peter Stoker C. Eng. – Director, National Drug Prevention Alliance, UK

VOLUME 1, ISSUE 3

The Effectiveness of Needle Exchange Programmes for HIV Prevention - A Critical Review
Kerstin Käll, Ulric Hermansson, Ellen J. Amundsen, Klas Rönnbäck and Sten Rönnberg
A Critical Evaluation of the Effects of Safe Injection Facilities
Garth Davies
The Public Health Dangers of Drug Abuse in Prisons
Ian Oliver
History of Harm Reduction - Provenance and Politics, Part 2
Peter Stoker C. Eng.

VOLUME 1, ISSUE 2
Harm Reduction: Background, Outcomes, Appraisals and Implications for Future Drug Policy
go to this issue

The Lure and the Loss of Harm Reduction in UK Drug Policy and Practice
Neil McKegancy, BA, MSc, PhD, FRSA
A Critique of Canada’s INSITE Injection Site and its Parent Philosophy: Implications and Recommendations for Policy Planning
Colin Mangham, PhD
Is It Harm Reduction - Or Harm Continuation?
Peter O’Loughlin
History of Harm Reduction – Provenance and Politics, Part 1
Peter Stoker C. Eng.

VOLUME 1, ISSUE 1
Marijuana: The present challenge and the future of cannabinoid research
go to this issue

Marijuana and cannabinoid research: Current status and future potential
Eric A. Voth, MD, FACP
From Mockery to Medicine: The Story of the Development of a Serious Modern Medicine
Andrea G. Barthwell, MD, FASAM
Marijuana and Adolescents
Edward A. Jacobs, MD, FAAP